BCYC
Price
$7.24
Change
-$0.04 (-0.55%)
Updated
Jun 27, 04:59 PM (EDT)
Capitalization
501.4M
34 days until earnings call
GNTA
Price
$3.10
Change
+$0.05 (+1.64%)
Updated
Jun 27, 04:54 PM (EDT)
Capitalization
56.7M
Interact to see
Advertisement

BCYC vs GNTA

Header iconBCYC vs GNTA Comparison
Open Charts BCYC vs GNTABanner chart's image
Bicycle Therapeutics
Price$7.24
Change-$0.04 (-0.55%)
Volume$2.43K
Capitalization501.4M
Genenta Science SpA
Price$3.10
Change+$0.05 (+1.64%)
Volume$100
Capitalization56.7M
BCYC vs GNTA Comparison Chart in %
Loading...
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BCYC vs. GNTA commentary
Jun 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BCYC is a Buy and GNTA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 28, 2025
Stock price -- (BCYC: $7.24 vs. GNTA: $3.10)
Brand notoriety: BCYC and GNTA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BCYC: 69% vs. GNTA: 302%
Market capitalization -- BCYC: $501.4M vs. GNTA: $56.7M
BCYC [@Biotechnology] is valued at $501.4M. GNTA’s [@Biotechnology] market capitalization is $56.7M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BCYC’s FA Score shows that 1 FA rating(s) are green whileGNTA’s FA Score has 0 green FA rating(s).

  • BCYC’s FA Score: 1 green, 4 red.
  • GNTA’s FA Score: 0 green, 5 red.
According to our system of comparison, both BCYC and GNTA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BCYC’s TA Score shows that 5 TA indicator(s) are bullish.

  • BCYC’s TA Score: 5 bullish, 5 bearish.

Price Growth

BCYC (@Biotechnology) experienced а -2.43% price change this week, while GNTA (@Biotechnology) price change was +1.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +31.37%, and the average quarterly price growth was +12.88%.

Reported Earning Dates

BCYC is expected to report earnings on Jul 31, 2025.

GNTA is expected to report earnings on Mar 28, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BCYC($501M) has a higher market cap than GNTA($56.7M). GNTA YTD gains are higher at: -28.736 vs. BCYC (-48.286).
BCYCGNTABCYC / GNTA
Capitalization501M56.7M884%
EBITDA-200.61MN/A-
Gain YTD-48.286-28.736168%
P/E RatioN/AN/A-
Revenue25.7MN/A-
Total Cash793MN/A-
Total Debt8.33MN/A-
FUNDAMENTALS RATINGS
BCYC: Fundamental Ratings
BCYC
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
35

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BCYC
RSI
ODDS (%)
Bullish Trend 2 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 17 days ago
82%
Declines
ODDS (%)
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Aroon
ODDS (%)
Bullish Trend 2 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
BCYC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NBNRX15.09N/A
N/A
Neuberger Berman International Sel R3
FTTNX12.29N/A
N/A
Fidelity Advisor Asset Manager 30% M
MEMCX33.99N/A
N/A
MFS Emerging Markets Equity C
NRECX13.74N/A
N/A
Neuberger Berman Real Estate C
FCAOX12.37N/A
N/A
Fidelity Advisor Climate Action M

BCYC and

Correlation & Price change

A.I.dvisor indicates that over the last year, BCYC has been loosely correlated with INO. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if BCYC jumps, then INO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BCYC
1D Price
Change %
BCYC100%
-0.55%
INO - BCYC
55%
Loosely correlated
-6.22%
XNCR - BCYC
54%
Loosely correlated
-3.10%
RPTX - BCYC
51%
Loosely correlated
-1.42%
RLAY - BCYC
50%
Loosely correlated
-0.75%
RCUS - BCYC
45%
Loosely correlated
-6.47%
More

GNTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNTA has been loosely correlated with ROQAF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if GNTA jumps, then ROQAF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNTA
1D Price
Change %
GNTA100%
+1.81%
ROQAF - GNTA
37%
Loosely correlated
N/A
TNFA - GNTA
28%
Poorly correlated
+1.20%
BCYC - GNTA
26%
Poorly correlated
-0.55%
PHIO - GNTA
25%
Poorly correlated
-0.90%
SRRK - GNTA
24%
Poorly correlated
+0.93%
More